As of 2024-12-11, the Relative Valuation of Diagonal Bio AB (DIABIO.ST) is (0.64) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 SEK, the upside of Diagonal Bio AB based on Relative Valuation is -2627.4%.
The range of the Relative Valuation is (0.57) - (0.68) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 18.4x | 15.4x |
| Forward P/E multiples | 15.5x - 23.2x | 19.4x |
| Fair Price | (0.57) - (0.68) | (0.64) |
| Upside | -2355.0% - -2783.2% | -2627.4% |
| Date | P/E |
| 2024-12-02 | -0.81 |
| 2024-11-29 | -0.87 |
| 2024-11-28 | -0.80 |
| 2024-11-27 | -0.83 |
| 2024-11-26 | -0.87 |
| 2024-11-25 | -0.88 |
| 2024-11-22 | -0.92 |
| 2024-11-21 | -0.89 |
| 2024-11-20 | -0.91 |
| 2024-11-19 | -0.94 |
| 2024-11-18 | -0.98 |
| 2024-11-15 | -0.90 |
| 2024-11-14 | -0.94 |
| 2024-11-13 | -1.03 |
| 2024-11-12 | -0.95 |
| 2024-11-11 | -0.93 |
| 2024-11-08 | -0.97 |
| 2024-11-07 | -1.00 |
| 2024-11-06 | -0.87 |
| 2024-11-05 | -0.90 |
| 2024-11-04 | -1.01 |
| 2024-11-01 | -1.10 |
| 2024-10-31 | -1.15 |
| 2024-10-30 | -1.04 |
| 2024-10-29 | -0.98 |
| 2024-10-28 | -1.08 |
| 2024-10-25 | -1.18 |
| 2024-10-24 | -1.09 |
| 2024-10-23 | -0.95 |
| 2024-10-22 | -1.08 |
| 2024-10-21 | -0.95 |
| 2024-10-18 | -1.05 |
| 2024-10-17 | -1.09 |
| 2024-10-16 | -1.02 |
| 2024-10-15 | -1.05 |
| 2024-10-14 | -1.10 |
| 2024-10-11 | -1.19 |
| 2024-10-10 | -0.84 |
| 2024-10-09 | -0.95 |
| 2024-10-08 | -0.81 |
| 2024-10-07 | -0.87 |
| 2024-10-04 | -0.60 |
| 2024-10-03 | -0.24 |
| 2024-10-02 | -0.23 |
| 2024-10-01 | -0.23 |
| 2024-09-30 | -0.23 |
| 2024-09-27 | -0.26 |
| 2024-09-26 | -0.24 |
| 2024-09-25 | -0.23 |
| 2024-09-24 | -0.26 |